Testimonials

Natasha F., Ga.

I received a call within 5 minutes of submitting my request! I was amazed at the prompt response!
Ann M., Penn.

The service was great, prompt response. Thank you!
Joseph E., Al.

I received a call within 5 minutes of submitting my request! I was amazed at the prompt response! The service was great, prompt response. Thank you! I am telling others how much easier it is than to go through a phone book and look at ads.
Debra S., Ca.

I am telling others how much easier it is than to go through a phone book and look at ads.
Bob M., Ky.

I think your service is great! Without your help I would not have been able to find an attorney knowledgeable for my needs.
Ann M., Penn.

The service was great, prompt response. Thank you!
Aisha B., Md

The attorney that responded was very professional, resourceful, helpful and courteous to me in regards to my situation. Thank you.

Baycol Recall

Starting in 1999, Bayer and the FDA have had a shared, ongoing concern over the practice of co-prescribing statins, including Baycol, with gemfibrozil to achieve more aggressive effects on lipid levels.

Relative to other statins, the reporting rate of rhabdomyolysis with Baycol appears to be more pronounced when gemfibrozil is co-prescribed and also with high-dose therapy alone, especially when not used as directed. Rhabdomyolysis is a rare condition characterized by generalized muscle weakness.

Recently, Bayer concluded that labeling agreed upon with the FDA, as well as communication campaigns conducted by the company during the past two years, have not been effective enough to prevent rhabdomyolysis through the reduction of co-prescribing.

During recent discussions with the FDA, Bayer proposed the following actions:

Suspend marketing and distribution of Baycol
Conduct voluntary market withdrawal
Naturally, we are disappointed to be removing Baycol from the market.
Nonetheless, we believe this is the responsible course of action for patients and we remain committed to providing innovative and vital therapies to fight cardiovascular disease.
We realize that this decision will affect many patients on Baycol therapy and we regret the difficulties resulting from this course of action.

First Name:

Last Name:

Address:

Zipcode:

City:

State:

Primary Phone:

Email:

Tell us about your case.

By leaving this box checked, I agree that submission does not establish an attorney client relationship and may be reviewed by one or more law firms. I agree to receive future announcements from our firm and partners.

Baycol Recall

Please fix these first